Skip to content

GINKGO BIOWORKS HOLDINGS, INC.

DNA DNABW

CIK 0001830214

← back to feed
Revenue (TTM)
$146.15M
−25.1% YoY Q1 Mar 2026
Net Income (TTM)
−$310.7M
+42.8% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$5.31
+46.5% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
-210.7%
Q1 Mar 2026
Net Margin
-212.6%
Q1 Mar 2026
Free Cash Flow (TTM)
−$313.76M
Q1 Mar 2026
Cash
$143.86M
Q1 Mar 2026
Total Debt
—
Q1 Mar 2026
Shares Outstanding
61.66M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings